Literature DB >> 1591084

Lack of effect of tumour infiltrating lymphocytes in patients with metastatic melanoma who failed to respond to interleukin 2.

T Dorval, C Mathiot, M Brandely, M C Escande, W H Fridman, P Pouillart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1591084     DOI： 10.1016/s0959-8049(05)80107-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

Review 1.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

2.  A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma.

Authors:  A Ravaud; E Legrand; M M Delaunay; E Bussières; V Coulon; L Cany; S Huet; D Verdier; M Kind; F Chomy
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.